Hikma Pharmaceuticals (HKMPF) Stock Price, News & Analysis

Company Overview

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Key Stats

• Today's Range: $27.73 to $27.73
• 50-Day Range: $26.20 to $27.73
• 52-Week Range: $22.56 to $28.92
• Volume: N/A
• Average Volume: 100 shs
• Market Capitalization: $6.15 billion
• P/E Ratio: N/A
• Dividend Yield: 3.46%
• Price Target: N/A
• Consensus Rating: Strong Buy

HKMPF Stock Analysis - Frequently Asked Questions

How have HKMPF shares performed this year?

Hikma Pharmaceuticals' stock was trading at $24.12 on January 1st, 2025. Since then, HKMPF shares have increased by 15.0% and is now trading at $27.7301.
View the best growth stocks for 2025 here.

How do I buy shares of Hikma Pharmaceuticals?

Shares of HKMPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Record date for 5/1 Dividend: 3/21/2025
• Ex-Dividend for 5/1 Dividend: 3/21/2025
• Dividend Payable: 5/01/2025
• Today: 6/18/2025
• Next Earnings (Estimated): 8/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:HKMPF
• Previous Symbol: OTC:HKMPF
• CIK: N/A
• Web: www.hikma.com
• Phone: 442073992760
• Fax: 44-20-7399-2761
• Employees: 9,500
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.28
• Current Ratio: 1.14
• Quick Ratio: 0.65

Sales & Book Value

• Annual Sales: $3.13 billion
• Price / Sales: 1.97
• Cash Flow: $2.23 per share
• Price / Cash Flow: 12.43
• Book Value: $10.46 per share
• Price / Book: 2.65

Miscellaneous

• Outstanding Shares: 221,890,000
• Free Float: N/A
• Market Cap: $6.15 billion
• Optionable: Not Optionable
• Beta: 0.57